MA AMABELLE ABLAN: Open Payments
NPI 1093289399 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 10 payments from 8 companies in 2025. Trend: 2023 $1,373 · 2024 $720 · 2025 $1,009
Food & beverage: $1,009
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $209 |
| AstraZeneca Pharmaceuticals LP | 2 | $208 |
| Amgen Inc. | 1 | $138 |
| ABIOMED | 1 | $126 |
| PFIZER INC. | 1 | $110 |
| UCB, Inc. | 1 | $107 |
| Corcept Therapeutics | 1 | $83 |
| ABBVIE INC. | 1 | $28 |
Products named: Livdelzi, AIRSUPRA, NURTEC ODT, Rystiggo, SAPHNELO, Epclusa, Korlym, UBRELVY.
Industry payments across TX — which companies pay providers there.
